ILTS Annual Congress

May 3, 2023 to May 6, 2023

De Doelen ICC Rotterdam
Schouwburgplein 50
3012 CL Rotterdam, Netherlands

The goal of the ILTS Annual Congress is to provide an excellent platform to deepen the education and knowledge of scientists, surgeons, anesthesiologists, hepatologists, critical care physicians, radiologists, pathologists, nurses, patients, and patient families. Join us to network and discuss the latest advances in the care of liver transplantation patients and receive state of the art updates in clinical and basic science.

Annual Meeting Website: https://2023.ilts.org/

Tagged In:

The Latest

Check out the most recent posts

Novel Oxygenation Technique for Hypothermic Machine Perfusion of Liver Grafts: Validation in Porcine Donation after Cardiac Death (DCD) Liver Model

Clinical Evidence

In a pre-clinical study using a porcine DCD model, Panayotova et al. sought to validate the novel technique of oxygen “pre-charge” for hypothermic machine perfusion (HMP) using the LifePort Liver Transporter. The study evaluated the effects of this preservation method...

David’s Transplant Journey

News

In this powerful video, we meet David, a liver recipient who shares his journey of needing a liver transplant. David speaks about the emotional and physical toll of waiting for a liver to become available, not knowing when or if he would receive that call. David takes...

Changing liver utilization and discard rates in clinical transplantation in the ex-vivo machine preservation era

Clinical Evidence

A recent review article by Azizieh et al. focused on the implementation of ex-vivo machine preservation and how it might change the perception of organ acceptability. By focusing on machine perfusion, they explored the effects of the different modalities on outcomes...

Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?

Clinical Evidence

In 2023, Malinoski et al. published the results from a pragmatic, adaptive, prospective, randomized trial that was conducted between August 10, 2017, and May 21, 2020 involving six OPOs in the US. They sought to determine whether targeted mild hypothermia is as...